We are live on ! Find out more
PPBT

Purple Biotech
PPBT

15 hedge funds and large institutions have $388K invested in Purple Biotech in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,420% more call options, than puts

Call options by funds: $76K | Put options by funds: $5K

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

73% more capital invested

Capital invested by funds: $224K → $388K (+$164K)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
$76K
Puts
$5K
Net Calls
+$71K
Net Calls Change
-$185K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$55.3K
2
Morgan Stanley
Morgan Stanley
New York
+$11.8K
3
FA
Fiduciary Alliance
South Carolina
+$9.69K
4
VVP
Venture Visionary Partners
Ohio
+$1.44K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$1.08K

Top Sellers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
-$19K
2
UBS Group
UBS Group
Switzerland
-$8.17K
3
BAM
Belpointe Asset Management
Nevada
-$4.65K
4
ASN
Advisory Services Network
Georgia
-$3.57K
5
AAS
Ameritas Advisory Services
Nebraska
-$1.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
KWA
1
Kingswood Wealth Advisors
California
$178K +$230K +640 New
Citadel Advisors
2
Citadel Advisors
Florida
$64.3K +$55.3K +154 +203%
Morgan Stanley
3
Morgan Stanley
New York
$41.3K +$11.8K +33 +29%
VVP
4
Venture Visionary Partners
Ohio
$19.1K +$1.44K +4 +6%
WAOI
5
Wealth Advisors of Iowa
Iowa
$18.5K +$1.08K +3 +5%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$17.7K – – –
RJA
7
Raymond James & Associates
Florida
$15.3K – – –
Simplex Trading
8
Simplex Trading
Illinois
$12K -$19K -53 -54%
FA
9
Fiduciary Alliance
South Carolina
$7.55K +$9.69K +27 New
TWC
10
TD Waterhouse Canada
Ontario, Canada
$7.37K – – –
Group One Trading
11
Group One Trading
Illinois
$4.72K – – –
RhumbLine Advisers
12
RhumbLine Advisers
Massachusetts
$777 +$1.08K +3 New
GRP
13
Global Retirement Partners
California
$469 +$718 +2 New
NSIM
14
North Star Investment Management
Illinois
$418 – – –
Wells Fargo
15
Wells Fargo
California
$70 – – –
S
16
SignatureFD
Georgia
$31 – – –
UBS Group
17
UBS Group
Switzerland
– -$8.17K -23 Closed
BAM
18
Belpointe Asset Management
Nevada
– -$4.65K -13 Closed
ASN
19
Advisory Services Network
Georgia
– -$3.57K -10 Closed
AAS
20
Ameritas Advisory Services
Nebraska
– -$1.9K -5 Closed

PPBT Hedge Fund Activity: Q2 2023 in Review

15 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q2 2023, worth a combined $388K — up 73% from $224K a quarter earlier.

Fund positioning in PPBT was balanced in Q2 2023: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $55.3K. The largest seller was Simplex Trading, cutting an estimated $19K.

  • 15 institutional investors held Purple Biotech (PPBT) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $388K of Purple Biotech stock for Q2 2023, up 73% quarter-over-quarter.
  • 4 funds opened new Purple Biotech positions in Q2 2023 and 4 closed out, a net change of 0 holders.
  • The largest Purple Biotech buyer in Q2 2023 was Citadel Advisors, an estimated $55.3K added.
  • The largest Purple Biotech seller in Q2 2023 was Simplex Trading, an estimated $19K sold.

Based on aggregated 13F filings for Q2 2023.